Nanobiotix (NBTX) Non-Current Debt: 2019-2025

  • Nanobiotix's Non-Current Debt rose 10.68% to $52.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $52.6 million, marking a year-over-year increase of 10.68%. This contributed to the annual value of $49.1 million for FY2024, which is 0.27% down from last year.
  • Per Nanobiotix's latest filing, its Non-Current Debt stood at $52.6 million for Q2 2025, which was up 7.14% from $49.1 million recorded in Q4 2024.
  • In the past 5 years, Nanobiotix's Non-Current Debt ranged from a high of $53.0 million in Q2 2021 and a low of $38.4 million during Q2 2022.
  • Moreover, its 3-year median value for Non-Current Debt was $49.0 million (2023), whereas its average is $49.3 million.
  • In the last 5 years, Nanobiotix's Non-Current Debt fell by 27.48% in 2022 and then grew by 24.80% in 2023.
  • Quarterly analysis of 5 years shows Nanobiotix's Non-Current Debt stood at $43.3 million in 2021, then dropped by 27.48% to $38.4 million in 2022, then grew by 24.80% to $49.0 million in 2023, then rose by 0.27% to $49.1 million in 2024, then increased by 10.68% to $52.6 million in 2025.
  • Its Non-Current Debt was $52.6 million in Q2 2025, compared to $49.1 million in Q4 2024 and $47.6 million in Q2 2024.